DeVane, C. Lindsay

Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana

Zhu, H.-J., Wang, J.-S., Markowitz, J. S., Donovan, J. L., Gibson, B. B., Gefroh, H. A., & DeVane, C. L. (2006) · The Journal of Pharmacology and Experimental Therapeutics

Drug Transport and Resistance MechanismsCannabis and Cannabinoid Research

Cited by 192

A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study

Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 109

The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT1A receptor

Markowitz, J. S., Markowitz, J. S., DeVane, C. L., Ramamoorthy, S., Zhu, H.-J., & Zhu, H.-J. (2009) · Die Pharmazie

Neurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and Signaling

Cited by 68

Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial

DeVane, C. L., Charles, J. M., Abramson, R. K., Williams, J. E., Carpenter, L. A., Raven, S., Gwynette, F., Stuck, C. A., Geesey, M. E., Bradley, C., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Autism Spectrum Disorder ResearchSchizophrenia research and treatment

Cited by 60

Rifampin‐induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline

Markowitz, J. S., & DeVane, C. L. (2000) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 34